WuXi AppTec (OTCMKTS:WUXAY) Reaches New 12-Month High – Should You Buy?

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) hit a new 52-week high on Thursday . The company traded as high as $21.00 and last traded at $21.00, with a volume of 809 shares trading hands. The stock had previously closed at $20.21.

Analyst Ratings Changes

Separately, Zacks Research raised shares of WuXi AppTec to a “hold” rating in a research report on Monday, April 13th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy”.

WuXi AppTec Price Performance

The business’s 50-day moving average is $17.35 and its two-hundred day moving average is $15.75.

WuXi AppTec (OTCMKTS:WUXAY) last announced its quarterly earnings data on Monday, April 27th. The company reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.18 by $0.05. The firm had revenue of $1.82 billion for the quarter, compared to analysts’ expectations of $1.59 billion.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.